Jazz Pharmaceuticals Shares Down 20.7% Since SmarTrend's Sell Call (JAZZ)

SmarTrend identified a Downtrend for Jazz Pharmaceuticals (NASDAQ:JAZZ) on December 10th, 2015 at $138.89. In approximately 2 months, Jazz Pharmaceuticals has returned 20.74% as of today's recent price of...